AGM outcome: Dividend of Rs 57 per share approved, all 6 resolutions passed
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GlaxoSmithKline Pharmaceuticals held its 101st AGM on June 30, 2026 via video conferencing. All 6 resolutions were approved with requisite majority, including adoption of audited financial statements, dividend of Rs 57 per equity share for FY ending March 2026, re-appointment of Mr. Subesh Williams (99.48 percent in favour), and commission to independent directors passed as special resolution (99.96 percent in favour). Cost auditor remuneration was also ratified for FY26 and FY27. Total of 132,132 shareholders were on record date.
Shareholders to receive Rs 57 per share dividend. Near-unanimous approval signals stable governance and management continuity.